Sandra Tuyaerts

3.2k total citations
55 papers, 2.1k citations indexed

About

Sandra Tuyaerts is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sandra Tuyaerts has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 35 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Sandra Tuyaerts's work include Immunotherapy and Immune Responses (35 papers), Cancer Immunotherapy and Biomarkers (22 papers) and CAR-T cell therapy research (17 papers). Sandra Tuyaerts is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), Cancer Immunotherapy and Biomarkers (22 papers) and CAR-T cell therapy research (17 papers). Sandra Tuyaerts collaborates with scholars based in Belgium, Netherlands and United States. Sandra Tuyaerts's co-authors include Kris Thielemans, Carlo Heirman, Aude Bonehill, Jurgen Corthals, Frédéric Amant, Karine Breckpot, Bart Neyns, Anke Vanderstraeten, Annelies Michiels and An M. T. Van Nuffel and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Sandra Tuyaerts

53 papers receiving 2.1k citations

Peers

Sandra Tuyaerts

IMMUN

ONCOL

GENET

Hiroaki Shime Japan

Cheryl Eppolito United States

Pia M. Martensen Denmark

Melanie R. Rutkowski United States

Laurent Gorvel France

Hossein Asgarian‐Omran Iran

Fazel Shokri Iran

Katsuyuki Adachi Japan

Jérôme Thiery France

Paul Costeas Cyprus

Hiroaki Shime Japan

Sandra Tuyaerts

1.2k ×0.8

IMMUN

651 ×0.7

366 ×0.4

ONCOL

82 ×0.3

GENET

61 ×0.4

Citations per year, relative to Sandra Tuyaerts Sandra Tuyaerts (= 1×) peers Hiroaki Shime

Countries citing papers authored by Sandra Tuyaerts

Since Specialization

Citations

This map shows the geographic impact of Sandra Tuyaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Tuyaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Tuyaerts more than expected).

Fields of papers citing papers by Sandra Tuyaerts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Tuyaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Tuyaerts. The network helps show where Sandra Tuyaerts may publish in the future.

Co-authorship network of co-authors of Sandra Tuyaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Tuyaerts. A scholar is included among the top collaborators of Sandra Tuyaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Tuyaerts. Sandra Tuyaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duerinck, Johnny, Xenia Geeraerts, Freya Vaeyens, et al.. (2024). Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma. Neuro-Oncology. 26(12). 2208–2221. 11 indexed citations

Awad, Robin Maximilian, Ann De Becker, Ivan Van Riet, et al.. (2024). Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity. Journal for ImmunoTherapy of Cancer. 12(11). e009110–e009110. 7 indexed citations

Schwarze, Julia Katharina, Xenia Geeraerts, Sandra Tuyaerts, & Bart Neyns. (2023). Current “state of the art” on dendritic cell-based cancer vaccines in melanoma. Current Opinion in Oncology. 35(2). 87–93. 5 indexed citations

Jaeghere, Emiel A. De, Sandra Tuyaerts, Ann Belmans, et al.. (2022). 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial. International Journal of Gynecological Cancer. 32. A187–A188.

Neyns, Bart, Jürgen Schwarze, Gil Awada, et al.. (2021). 342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial. Annals of Oncology. 32. S516–S517. 1 indexed citations

Dufait, Inès, Julia Katharina Schwarze, Ivan Van Riet, et al.. (2021). Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells. Frontiers in Immunology. 12. 733506–733506. 7 indexed citations

Marinelli, Oliviero, Daniela Annibali, Maria Beatrice Morelli, et al.. (2020). Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer. Frontiers in Oncology. 10. 538064–538064. 12 indexed citations

Marinelli, Oliviero, Daniela Annibali, Cristina Aguzzi, et al.. (2019). The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies. Frontiers in Oncology. 9. 1073–1073. 34 indexed citations

Vanderstraeten, Anke, Rieta Van Bree, Godelieve Verbist, et al.. (2015). In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine Cancer. Journal of Immunotherapy. 38(6). 239–249. 9 indexed citations

10.

Madondo, Mutsa, Sandra Tuyaerts, Brit B. Turnbull, et al.. (2014). Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations. Journal of Translational Medicine. 12(1). 179–179. 9 indexed citations

11.

Vanderstraeten, Anke, C. Luyten, Godelieve Verbist, Sandra Tuyaerts, & Frédéric Amant. (2014). Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy. Cancer Immunology Immunotherapy. 63(6). 545–557. 101 indexed citations

12.

Nuffel, An M. T. Van, Sandra Tuyaerts, Daphné Benteyn, et al.. (2012). Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens. Journal of Immunological Methods. 377(1-2). 23–36. 17 indexed citations

13.

Tuyaerts, Sandra. (2011). Dendritic cell therapy for oncology roundtable conference. PubMed. 9(1). 1–1. 13 indexed citations

14.

Bonehill, Aude, Sandra Tuyaerts, An M. T. Van Nuffel, et al.. (2008). Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA. Molecular Therapy. 16(6). 1170–1180. 151 indexed citations

15.

Michiels, Annelies, Sandra Tuyaerts, Aude Bonehill, et al.. (2008). Delivery of Tumor-Antigen-Encoding mRNA into Dendritic Cells for Vaccination. Methods in molecular biology. 423. 155–163. 9 indexed citations

16.

Heirman, Carlo, Sandra Tuyaerts, Jurgen Corthals, et al.. (2007). CD83 expression on dendritic cells and T cells: Correlation with effective immune responses. European Journal of Immunology. 37(3). 686–695. 171 indexed citations

17.

Michiels, Annelies, Sandra Tuyaerts, Aude Bonehill, et al.. (2005). Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Therapy. 12(9). 772–782. 81 indexed citations

18.

Bonehill, Aude, Carlo Heirman, Sandra Tuyaerts, et al.. (2004). Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules. The Journal of Immunology. 172(11). 6649–6657. 176 indexed citations

19.

Dullaers, Mélissa, Karine Breckpot, Sonja Van Meirvenne, et al.. (2004). Side-by-Side Comparison of Lentivirally Transduced and mRNA-Electroporated Dendritic Cells: Implications for Cancer Immunotherapy Protocols. Molecular Therapy. 10(4). 768–779. 72 indexed citations

20.

Tuyaerts, Sandra, Annelies Michiels, Jurgen Corthals, et al.. (2003). Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells. Cancer Gene Therapy. 10(9). 696–706. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact